Protagonist Therapeutics Inc <PTGX.O>: TD Cowen Raises Target Price to $155 From $100
PTGX•Related News
Houthi Red Sea blockade would lift oil prices, but workarounds could limit impact
XLE•
Saudi condemns Houthi maritime blockade threat; group warns of escalation
XLE•
Fulcrum Therapeutics 10% owner Kevin Tang acquires $594,132 of common shares
FULC•
Guidewire CEO Michael George Rosenbaum disposes of 1,200 common shares worth $176,904
GWRE•
Icahn Enterprises to sell auto-service chain Pep Boys to Mavis for $700 million, WSJ reports
IEP•